VistaGen Therapeutics (VTGN) Proxy filing summary

Executive summary

• Annual Meeting scheduled for September 10, 2026, to be held virtually at 9:00 am PDT.

• Proxy materials and annual report are available online, with options for electronic or paper delivery.

• Shareholders are encouraged to review all proxy materials before voting and can vote online.

Voting matters and shareholder proposals

• Election of four director nominees: Jon S. Saxe, Ann M. Cunningham, Shawn K. Singh, and Douglas J. Williamson.

• Advisory vote to approve compensation of named executive officers.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending March 31, 2027.

• Consideration of any other matters that may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and FOR the executive compensation and auditor ratification proposals.